Key result
Youth with type 2 diabetes have ~153% higher odds of cardiovascular autonomic neuropathy versus type 1.
Why the study?
Cardiovascular autonomic neuropathy is an overlooked yet common and serious complication of diabetes, prompting an evaluation of its frequency and cardiometabolic risk factor associations in youth.
Does type 2 diabetes compared to type 1 diabetes increase the risk of cardiovascular autonomic neuropathy in youth?
Cohort (n=1,219)
No
Does type 2 diabetes compared to type 1 diabetes increase the risk of cardiovascular autonomic neuropathy in youth?
Youth with type 2 diabetes have a significantly higher frequency of cardiovascular autonomic neuropathy and other cardiometabolic complications compared to those with type 1 diabetes, despite shorter disease duration.
Supports closer monitoring for autonomic neuropathy in youth with type 2 diabetes; hypothesis-generating and requires prospective confirmation.
Background Cardiovascular autonomic neuropathy (CAN) is an overlooked but common and serious diabetes complication. We examined CAN in youth with diabetes and associations with cardiovascular risk factors. Methods This was a prospective cohort of youth aged <20 years with type 2 or type 1 diabetes (n=66/1153, median age 15.4/16.5 years, duration 1.7/8.0 years), assessed between 2009-2020. CAN was defined as ≥2 abnormal heart rate variability measures across time, geometric, and frequency domains. Obesity was defined as BMI ≥95th percentile and severe obesity as ≥120% of 95th percentile. Multivariable generalized estimating equations (GEE) were used to examine putative risk factors for CAN, including diabetes type, obesity and HbA1c. Results At most recent assessment, youth with type 2 vs type 1 diabetes had median: HbA1c 7.1% (54 mmol/mol) vs 8.7% (72 mmol/mol) and BMI SDS (2.0 vs 0.7); frequency of CAN (47% vs 27%), peripheral nerve abnormality (47% vs 25%), hypertension (29% vs 12%), albuminuria (21% vs 3%), and severe obesity (35% vs 2%). In multivariable GEE, CAN was associated with type 2 diabetes: Odds Ratio 2.53, 95% CI 1.46, 4.38, p=0.001, higher BMI SDS: 1.49, 95% CI 1.29, 1.73, p<0.0001, and obesity: 2.09, 95% CI 1.57, 2.78, p<0.0001. Conclusions Youth with type 2 diabetes have a higher frequency of CAN, peripheral nerve abnormality, hypertension, albuminuria and severe obesity despite shorter diabetes duration and younger age. Our findings highlight the importance of targeting modifiable risk factors to prevent cardiovascular disease in youth with diabetes. This article is protected by copyright. All rights reserved.
No takes yet. Share an insight, caveat, or question.
Varley et al. (2022) conducted a cohort in Type 1 and Type 2 Diabetes (n=1,219). Type 2 diabetes vs. Type 1 diabetes was evaluated on Frequency of cardiovascular autonomic neuropathy (CAN) (OR 2.53, 95% CI 1.46, 4.38, p=0.001). Youth with type 2 diabetes had a significantly higher frequency of cardiovascular autonomic neuropathy compared to those with type 1 diabetes (47% vs 27%, OR 2.53).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: